Question Bank

Antiplatelet & Thrombolytic Drugs — Hematology & GI Pharmacology

Pharmacology Question Bank

← Back to Question Bank

Question Bank Pharmacology Hematology & GI Pharmacology Antiplatelet & Thrombolytic Drugs

Pharmacology Question Bank

Antiplatelet & Thrombolytic Drugs

Hematology & GI Pharmacology · Antiplatelet & Thrombolytic Drugs · medium

Question 1 of 5

20% complete

0 s

Accuracy

No answers yet

Quick Tip

Question Navigator

Current

Correct

Incorrect

Unanswered

Antiplatelet & Thrombolytic Drugs MCQs: practice questions

Sample Antiplatelet & Thrombolytic Drugs multiple-choice questions from Hematology & GI Pharmacology.

Which antiplatelet drug irreversibly inhibits platelet cyclooxygenase and decreases thromboxane A2 production?
- A. Warfarin
- B. Aspirin
- C. Dipyridamole
- D. Heparin
- E. Alteplase
Which thrombolytic is a recombinant fragment of human tPA?
- A. Streptokinase
- B. Urokinase
- C. Reteplase
- D. Heparin
- E. Warfarin
Which thrombolytic acts on both circulating plasminogen and fibrin-bound plasminogen?
- A. Warfarin
- B. Reteplase
- C. Alteplase
- D. Tenecteplase
- E. Streptokinase
Which agent prevents fibrinogen-mediated platelet aggregation by blocking the final common platelet aggregation receptor?
- A. Abciximab
- B. Alteplase
- C. Vitamin K
- D. Warfarin
- E. Heparin
Which drug inhibits platelet aggregation rather than directly dissolving an existing fibrin clot?
- A. Clopidogrel
- B. Reteplase
- C. Alteplase
- D. Streptokinase
- E. Urokinase
Which adverse effect is especially important when GPIIb/IIIa inhibitors are combined with heparin?
Which agent is used to reduce platelet aggregation by inhibiting ADP-mediated activation?
What is the principal adverse effect of GPIIb/IIIa inhibitors?
Which P2Y12 inhibitor has the same mechanism as ticlopidine but fewer adverse effects and a very low frequency of neutropenia?
Which drug is used during percutaneous coronary intervention and is administered by infusion as a GPIIb/IIIa inhibitor?
Which thrombolytic is a bacterial protein that activates plasminogen nonenzymatically?
Which enzyme directly degrades fibrin in the fibrinolytic pathway?
Which platelet receptor is directly targeted by abciximab?
Which thrombolytic has a half-life long enough to permit bolus administration?
Which adverse effect is common to all thrombolytic drugs?
Which thrombolytic is derived from streptococci?
Which drug is a direct platelet inhibitor rather than an anticoagulant?
Which antiplatelet drug is a platelet COX inhibitor?
Which drug is a chimeric monoclonal antibody fragment?
Which treatment most directly promotes fibrin clot dissolution?
Which thrombolytics are engineered forms of human tPA with longer half-lives?
Which thrombolytic is most specific for fibrin-bound plasminogen?
Which GPIIb/IIIa inhibitor is a small synthetic peptide?
Which antiplatelet class blocks the platelet ADP P2Y12 receptor?
Which thrombolytic is recombinant human tissue plasminogen activator?
Which drug is a peptide mimetic that binds platelet GPIIb/IIIa?
Which antithrombotic agent impairs fibrin polymerization and platelet function in vivo by an unclear mechanism?
Which drug is a GPIIb/IIIa inhibitor?
What is the immediate precursor activated by thrombolytic therapy to generate plasmin?
Which thrombolytic is produced in the kidney and activates plasminogen?

Antiplatelet & Thrombolytic Drugs — Hematology & GI Pharmacology

Antiplatelet & Thrombolytic Drugs MCQs: practice questions

Which antiplatelet drug irreversibly inhibits platelet cyclooxygenase and decreases thromboxane A2 production?

Which thrombolytic is a recombinant fragment of human tPA?

Which thrombolytic acts on both circulating plasminogen and fibrin-bound plasminogen?

Which agent prevents fibrinogen-mediated platelet aggregation by blocking the final common platelet aggregation receptor?

Which drug inhibits platelet aggregation rather than directly dissolving an existing fibrin clot?

Which adverse effect is especially important when GPIIb/IIIa inhibitors are combined with heparin?

Which agent is used to reduce platelet aggregation by inhibiting ADP-mediated activation?

What is the principal adverse effect of GPIIb/IIIa inhibitors?

Which P2Y12 inhibitor has the same mechanism as ticlopidine but fewer adverse effects and a very low frequency of neutropenia?

Which drug is used during percutaneous coronary intervention and is administered by infusion as a GPIIb/IIIa inhibitor?

Which thrombolytic is a bacterial protein that activates plasminogen nonenzymatically?

Which enzyme directly degrades fibrin in the fibrinolytic pathway?

Which platelet receptor is directly targeted by abciximab?

Which thrombolytic has a half-life long enough to permit bolus administration?

Which adverse effect is common to all thrombolytic drugs?

Which thrombolytic is derived from streptococci?

Which drug is a direct platelet inhibitor rather than an anticoagulant?

Which antiplatelet drug is a platelet COX inhibitor?

Which drug is a chimeric monoclonal antibody fragment?

Which treatment most directly promotes fibrin clot dissolution?

Which thrombolytics are engineered forms of human tPA with longer half-lives?

Which thrombolytic is most specific for fibrin-bound plasminogen?

Which GPIIb/IIIa inhibitor is a small synthetic peptide?

Which antiplatelet class blocks the platelet ADP P2Y12 receptor?

Which thrombolytic is recombinant human tissue plasminogen activator?

Which drug is a peptide mimetic that binds platelet GPIIb/IIIa?

Which antithrombotic agent impairs fibrin polymerization and platelet function in vivo by an unclear mechanism?

Which drug is a GPIIb/IIIa inhibitor?

What is the immediate precursor activated by thrombolytic therapy to generate plasmin?

Which thrombolytic is produced in the kidney and activates plasminogen?